↓ Skip to main content

microRNAs as neuroregulators, biomarkers and therapeutic agents in neurodegenerative diseases

Overview of attention for article published in Cellular and Molecular Life Sciences, November 2015
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (86th percentile)
  • High Attention Score compared to outputs of the same age and source (81st percentile)

Mentioned by

news
1 news outlet
twitter
4 X users

Citations

dimensions_citation
97 Dimensions

Readers on

mendeley
125 Mendeley
Title
microRNAs as neuroregulators, biomarkers and therapeutic agents in neurodegenerative diseases
Published in
Cellular and Molecular Life Sciences, November 2015
DOI 10.1007/s00018-015-2093-x
Pubmed ID
Authors

Indranil Basak, Ketan S. Patil, Guido Alves, Jan Petter Larsen, Simon Geir Møller

Abstract

The last decade has experienced the emergence of microRNAs as a key molecular tool for the diagnosis and prognosis of human diseases. Although the focus has mostly been on cancer, neurodegenerative diseases present an exciting, yet less explored, platform for microRNA research. Several studies have highlighted the significance of microRNAs in neurogenesis and neurodegeneration, and pre-clinical studies have shown the potential of microRNAs as biomarkers. Despite this, no bona fide microRNAs have been identified as true diagnostic or prognostic biomarkers for neurodegenerative disease. This is mainly due to the lack of precisely defined patient cohorts and the variability within and between individual cohorts. However, the discovery that microRNAs exist as stable molecules at detectable levels in body fluids has opened up new avenues for microRNAs as potential biomarker candidates. Furthermore, technological developments in microRNA biology have contributed to the possible design of microRNA-mediated disease intervention strategies. The combination of these advancements, with the availability of well-defined longitudinal patient cohort, promises to not only assist in developing invaluable diagnostic tools for clinicians, but also to increase our overall understanding of the underlying heterogeneity of neurodegenerative diseases. In this review, we present a comprehensive overview of the existing knowledge of microRNAs in neurodegeneration and provide a perspective of the applicability of microRNAs as a basis for future therapeutic intervention strategies.

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 125 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Portugal 1 <1%
Canada 1 <1%
Unknown 123 98%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 24 19%
Student > Master 21 17%
Student > Bachelor 13 10%
Researcher 11 9%
Professor > Associate Professor 9 7%
Other 19 15%
Unknown 28 22%
Readers by discipline Count As %
Agricultural and Biological Sciences 21 17%
Biochemistry, Genetics and Molecular Biology 20 16%
Neuroscience 18 14%
Medicine and Dentistry 12 10%
Pharmacology, Toxicology and Pharmaceutical Science 10 8%
Other 14 11%
Unknown 30 24%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 June 2016.
All research outputs
#3,108,935
of 23,794,258 outputs
Outputs from Cellular and Molecular Life Sciences
#465
of 4,151 outputs
Outputs of similar age
#52,344
of 390,842 outputs
Outputs of similar age from Cellular and Molecular Life Sciences
#10
of 55 outputs
Altmetric has tracked 23,794,258 research outputs across all sources so far. Compared to these this one has done well and is in the 86th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,151 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.0. This one has done well, scoring higher than 88% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 390,842 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 86% of its contemporaries.
We're also able to compare this research output to 55 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 81% of its contemporaries.